可调节光的类胺联合组装的工程纳米结构
Ruoyang Zhao1, Xinmin Zhao2, Feng Gao3
1Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou 325001, China.
Journal of colloid and interface science
|September 3, 2025
概括
科学家设计了可调节光的类胺联合组件. 疏水核增强了光,并使得向癌细胞死亡成为可能,为生物应用提供了新的设计方法.
科学领域:
- 超分子化学
- 材料科学
- 生物物理
背景情况:
- 对于可调节的光,对合成-甲醇胺联合组件中的疏水微环境的精确控制至关重要.
- 现有的方法在实现这种精确的工程方面面临挑战.
研究的目的:
- 开发一种超分子设计策略,用于在酸胺联合组件中设计疏水性封闭.
- 为了实现可编程的光调节和有针对性的生物应用.
主要方法:
- 使用序列特异性 (GYK三,Ac-IIIGYK-NH2六) 和具有不同疏水性的甲基胺,创建了层次的纳米结构.
- 使用分子模拟,高性能液体染色学 (HPLC),原子力显微镜 (AFM) 和光谱学来研究结构动力学.
主要成果:
- 疏水组形成了紧的核心,将染色体从水火中分离出来,并显著提高了光强度.
- 通过分子动力学模拟证实了减少水的透和延长激子寿命.
- 在B16黑色素瘤细胞中表现出选择性细胞毒性.
结论:
- -甲基胺界面相互作用控制着疏水性限制,为超分子设计提供了范式.
- 这种方法使可编程的光调节成为可能,并为包括癌症治疗在内的有针对性的生物医学应用开辟了道路.
更多相关视频
12:51A 'Plug and Play' Method to Create Water-dispersible Nanoassemblies Containing an Amphiphilic Polymer, Organic Dyes and Upconverting Nanoparticles
Published on: November 14, 2015
10.0K
09:11Synthesis of Near-Infrared Emitting Gold Nanoclusters for Biological Applications
Published on: March 22, 2020
7.9K
相关概念视频
Pulse rhythm
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Disturbances in Heart Rhythm
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Holter Monitor: 24-Hour Monitoring
Holter monitoring is a continuous electrocardiography (ECG) recording that tracks the heart's electrical activity over an extended period, generally 24 to 48 hours. This noninvasive diagnostic tool detects irregular heart rhythms that may not be captured during a standard ECG performed in a clinical setting.DeviceThe Holter monitor is a portable, small device connected to several electrodes on the patient's chest. These electrodes detect the heart's electrical signals and transmit them to the...
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
Dysrhythmias V: Evaluating Dysrhythmias
Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
